BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30523241)

  • 1. Combined Use of Circulating miR-133a and NT-proBNP Improves Heart Failure Diagnostic Accuracy in Elderly Patients.
    Guo M; Luo J; Zhao J; Shang D; Lv Q; Zang P
    Med Sci Monit; 2018 Dec; 24():8840-8848. PubMed ID: 30523241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.
    Ellis KL; Cameron VA; Troughton RW; Frampton CM; Ellmers LJ; Richards AM
    Eur J Heart Fail; 2013 Oct; 15(10):1138-47. PubMed ID: 23696613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of circulating microRNA-19b in heart failure.
    Zhang L; Xu RL; Liu SX; Dong SH; Zhao XX; Zhang BL
    Eur J Clin Invest; 2020 Nov; 50(11):e13308. PubMed ID: 32663314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    Wong LL; Zou R; Zhou L; Lim JY; Phua DCY; Liu C; Chong JPC; Ng JYX; Liew OW; Chan SP; Chen YT; Chan MMY; Yeo PSD; Ng TP; Ling LH; Sim D; Leong KTG; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lund M; Devlin G; Troughton R; Cameron VA; Doughty RN; Lam CSP; Too HP; Richards AM
    J Am Coll Cardiol; 2019 Mar; 73(11):1300-1313. PubMed ID: 30898206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients.
    Al-Hayali MA; Sozer V; Durmus S; Erdenen F; Altunoglu E; Gelisgen R; Atukeren P; Atak PG; Uzun H
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31109008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.
    Lin CW; Zeng XL; Zhang JF; Meng XH
    J Card Fail; 2014 Mar; 20(3):168-73. PubMed ID: 24361777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
    Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.
    Fan KL; Zhang HF; Shen J; Zhang Q; Li XL
    Indian Heart J; 2013; 65(1):12-6. PubMed ID: 23438607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people.
    Bombelli M; Maloberti A; Rossi S; Rea F; Corrao G; Bonicelli Della Vite C; Mancia G; Grassi G
    Arch Gerontol Geriatr; 2015; 61(2):296-300. PubMed ID: 25991044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
    J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.